Establishment Labs Holdings vs Orthopediatrics
Orthopediatrics reported revenue of $236 million in fiscal 2025, about the same as Establishment Labs Holdings' $211 million in fiscal 2025. Establishment Labs Holdings' revenue grew 27.1% in its latest year, and Orthopediatrics' grew 15.4%. Establishment Labs Holdings had an operating margin of -18.5%, against -16.6% at Orthopediatrics. Free cash flow was −$57 million at Establishment Labs Holdings and −$16 million at Orthopediatrics.
Side by side
| Establishment Labs Holdings | Orthopediatrics | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $211M | $236M |
| Revenue growth | 27.1% | 15.4% |
| Revenue growth a year, last 5 years | 20.0% | 27.2% |
| Gross margin | 69.3% | 73.0% |
| Operating margin | −18.5% | −16.6% |
| Net margin | −24.2% | −16.8% |
| Free cash flow | −$57M | −$16M |
| Free cash flow margin | −27.0% | −6.8% |
| Return on capital | −39.0% | −8.2% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 5.2% | 1.6% |
| Last close | $70.75 | $32.35 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | sold $35.5 million | — |
| Piotroski F-score | 3 of 9 | 4 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Establishment Labs HoldingsOrthopediatrics
Operating margin
Percent of revenue
Establishment Labs HoldingsOrthopediatrics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Establishment Labs HoldingsOrthopediatrics
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Establishment Labs Holdings and Orthopediatrics pages.